Goldman Sachs Starts Medivation (MDVN) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Xtandi Congressional Letter and CFO Change a Modest Negative at Worst for Medivation (MDVN) - UBS
March 29, 2016 8:38 AM EDTUBS Analyst, Matthew Roden, sees the Medivation (NASDAQ: MDVN) CFO change as a positive and the Congressional letter threatening Xtandi pricing as a modest negative at worst. No change to Buy rating or $50 PT.
In the short term, the transition may lessen the recent acquisition premium that followed media M&A speculation, but adding a deal-oriented CFO to the management team could... More
After-Hours Stock Movers 03/28: (FL) (DCT) (ALDR) Higher; (ALXA) (GEVO) (PBYI) Lower (more...)
March 28, 2016 6:11 PM EDTAlexza Pharmaceuticals Inc. (NASDAQ: ALXA) 49.7% LOWER; warns it may shut-down if it is unable to source additional capital.
Gevo, Inc. (Nasdaq: GEVO) 21.7% LOWER; announced that it intends to offer and sell, subject to market and other conditions, Series C units, with each Series C unit consisting of one share of common stock, Series F warrants to purchase a certain number of shares of common stock and Series H warrants to purchase a certain number of... More
Members of Congress Ask NIH and HHS to Examine Xtandi Pricing (MDVN) - CNBC
March 28, 2016 4:41 PM EDTEleven members of Congress asked NIH and HHS to examine Xtandi pricing, according to CNBC, citing a letter. The headline sent shares of Medivation (Nasdaq: MDVN) sharply lower after-hours.
12 congressmen ask NIH, HHS to examine $MDVN's Xtandi pricing. Letter here: https://t.co/kaodTemjvc
Meg Tirrell (@megtirrell) March 28, 2016... More